Clenia Cream

sulfacetamide sodium and sulfur

Dosage Form: cream and wash
Clenia® (sodium sulfacetamide 10% and sulfur 5%) Foaming Wash and Emollient Cream

Rx only

Clenia Cream Description

Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically, sodium sulfacetamide is N-[(4-aminophenyl) sulfonyl]-acetamide, monosodium salt, monohydrate.

The structural formula is:

Each gram of CLENIA® (sodium sulfacetamide 10% and sulfur 5%) Foaming Wash contains 100 mg of Sodium Sulfacetamide and 50 mg of Sulfur in a base containing Butylated Hydroxytoluene, NF, Disodium EDTA, USP, Disodium Oleamido MEA Sulfosuccinate, Fragrance, Glyceryl Stearate (and) PEG-100 Stearate, Magnesium Aluminum Silicate, NF, Methylparaben, NF, Mica, PEG-55 Propylene Glycol Oleate, Propylene Glycol, USP, Propylparaben, NF, Purified Water, USP, Silicon Dioxide, Sodium Cocyl Isethionate, Sodium Methyl Oleytaurate, Sodium Thiosulfate, USP, Stearic Acid, NF, Titanium Dioxide, Xanthan Gum, NF.

Each gram of CLENIA® (sodium sulfacetamide 10% and sulfur 5%0 Emollient Cream contains 100 mg of Sodium Sulfacetamide and 50 mg of Sulfur in a base containing Allantoin, Disodium EDTA, USP, Emulsifying Wax, NF, Fragrance, Glyceryl Monostearate, Isopropyl Myristate, NF, Methylparaben, NF, PEG-8 Stearate, Propylene Glycol, USP, Propylparaben, NF, Purified Water, USP, Sodium Thiosulfate, USP, Stearic Acid, NF, Xanthan Gum, NF.

Clenia Cream - Clinical Pharmacology

Sodium sulfacetamide exhibits antibacterial activity. It is believed to block bacterial growth by acting as a competitive antagonist of para-aminobenzoic acid (PABA). While absorption through intact skin has not been determined for sodium sulfacetamide, it is estimated that 1% of topically applied sulfur is absorbed. Although the exact mode of the keratolytic activity of sulfur is unknown, it is reported to result from the interaction of sulfur with the cysteine content of keratinocytes. In combination with sulfacetamide, sulfur has been reported to inhibit P. acnes, thereby reducing the associated inflammation.

INDICATIONS

CLENIA® (sodium sulfacetamide 10% and sulfur 5%) Foaming Wash and CLENIA® (sodium sulfacetamide 10% and sulfur 5%) Emollient Cream are indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

Contraindications

CLENIA® Foaming Wash and CLENIA® Emollient Cream are contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of these preparations. CLENIA® Foaming Wash and CLENIA® Emollient Cream are not to be used by patients with kidney disease.

Warnings

Although rare, hypersensitivity reactions to products containing sodium sulfacetamide may occur, including Stevens-Johnson syndrome and exfoliative dermatitis. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura, hemorrhagica, drug fever, jaundice and contact dermatitis indicate hypersensivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.

FOR EXTERNAL USE ONLY

Keep away from eyes. Keep out of reach of children.

Precautions

General

Although the object of this therapy is to achieve desquamation without irritation, this product poses a low potential for irritation, which may include reddening and scaling of the epidermis. Uncommon adverse reactions such as dryness, erythema, itching and edema may occur. Therefore, patients should be monitored for possible local irritation or sensitization. Use of the product should be discontinued if excessive irritation develops.

Information for Patients

Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. If excessive irritation develops, discontinue use and consult your physician.

Carcinogenesis, Mutagenesis and Impairment of Fertility

Long-term studies in animals have not been performed to evaluate carcinogenic potential.

Pregnancy

Pregnancy Category C

Animal reproduction studies have not been conducted with CLENIA® (sodium sulfacetamide 10% and sulfur 5%) Foaming Wash or CLENIA® (sodium sulfacetamide 10% and sulfur 5%) Emollient Cream. It is not known whether CLENIA® Foaming Wash and CLENIA® Emollient Cream can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. CLENIA® Foaming Wash and CLENIA® Emollient Cream should be used during pregnancy only if the potential benefit outweighs the potential risk.

Nursing Mothers

It is not known whether sodium sulfacetamide is excreted in human milk following topical use of CLENIA® Foaming Wash and CLENIA® Emollient Cream. However, small amounts of orally administered sulfonamides have been detected in human milk. In view of this and because many drugs are excreted in human milk, caution should be exercised when CLENIA® Foaming Wash and CLENIA® Emollient Cream is administered to a nursing woman.

Pediatric Use

Safety and effectiveness in children under the age of 12 have not been established.

Adverse Reactions

Although rare, adverse reactions such as dryness, erythema, itching and edema have been reported.

Clenia Cream Dosage and Administration

CLENIA® Foaming Wash

Wash affected areas once or twice daily or as directed by a physician. Wet skin, apply liberally and massage gently into skin for 10-20 seconds working into a full later. Rinse thoroughly and pat dry. Avoid contact with eyes and mucous membranes. If drying occurs, reduce cleansing time and rinse product off sooner or use less often.

CLENIA® Emollient Cream

Cleanse skin thoroughly before application. Apply a thin layer to affected areas 1-3 times daily or as directed by a physician. To minimize potential dryness, start with one application daily, then gradually increase to 2-3 times daily as needed or as directed by a physician.

How is Clenia Cream Supplied

CLENIA® (sodium sulfacetamide 10% and sulfur 5%) Foaming Wash is available in 6 oz (170 g) bottles (NDC 0245-0168-06) and 12 oz (340 g) bottles (NDC 0245-0168-12).

CLENIA® (sodium sulfacetamide 10% and sulfur 5%) Emollient Cream is available in 1 oz (28 g) tubes (NDC 0245-0169-01).

Store at 15-25°C (59-77°F). Avoid excessive heat.

Manufactured for

UPSHER-SMITH LABORATORIES, INC.

Minneapolis, MN 55447

by: Contract Pharmaceuticals Limited Canada

Mississauga, Ontario L5N 6L6

CANADA

US Patent 6,977,081 for CLENIA® (sodium sulfacetamide 10% and sulfur 5%) Emollient Cream

100556-01

Revised 0808

2004618

PRINCIPAL DISPLAY PANEL - 28 g tube label

NDC 0245-0169-01

Rx only

CLENIA®

(sodium sulfacetamide 10% and sulfur 5%)

Emollient Cream

1 oz (28 g)

UPSHER-SMITH

PRINCIPAL DISPLAY PANEL - 28 g tube carton

NDC 0245-0169-01

Rx only

CLENIA®

(sodium sulfacetamide 10% and sulfur 5%)

Emollient Cream

1 oz (28 g)

UPSHER-SMITH

PRINCIPAL DISPLAY PANEL - 3 g sample tube label

NDC 0245-0169-20

Rx only

CLENIA®

(sodium sulfacetamide 10% and sulfur 5%)

Emollient Cream

3 g (0.1 oz)

UPSHER-SMITH

PRINCIPAL DISPLAY PANEL - 3 g sample tube carton

NDC 0245-0169-20

Rx only

CLENIA®

(sodium sulfacetamide 10% and sulfur 5%)

Emollient Cream

20 tubes of 3 g (0.1 oz) each

PROFESSIONAL SAMPLES: Not for Sale

UPSHER-SMITH

PRINCIPAL DISPLAY PANEL - 170 g bottle label

NDC 0245-0168-06

Rx only

CLENIA®

(sodium sulfacetamide 10% and sulfur 5%)

Foaming Wash

6 oz (170 g)

UPSHER-SMITH

2003765

R0505

PRINCIPAL DISPLAY PANEL - 170 g bottle carton

NDC 0245-0168-06

Rx only

CLENIA®

(sodium sulfacetamide 10% and sulfur 5%)

Foaming Wash

6 oz (170 g)

UPSHER-SMITH

PRINCIPAL DISPLAY PANEL - 340 g bottle label

NDC 0245-0168-12

Rx only

CLENIA®

(sodium sulfacetamide 10% and sulfur 5%)

Foaming Wash

12 oz (340 g)

UPSHER-SMITH

2003771

R0505

PRINCIPAL DISPLAY PANEL - 340 g bottle carton

NDC 0245-0168-12

Rx only

CLENIA®

(sodium sulfacetamide 10% and sulfur 5%)

Foaming Wash

12 oz (340 g)

UPSHER-SMITH

PRINCIPAL DISPLAY PANEL - 5 g sample bottle label

NDC 0245-0168-20

Rx only

CLENIA®

(sodium sulfacetamide 10% and sulfur 5%)

Foaming Wash

5 g (0.2 oz)

UPSHER-SMITH

PRINCIPAL DISPLAY PANEL - 5 g sample bottle carton

NDC 0245-0168-20

Rx only

CLENIA®

(sodium sulfacetamide 10% and sulfur 5%)

Foaming Wash

20 packets of 5 g (0.2 oz) each

PROFESSIONAL SAMPLES: Not for Sale

UPSHER-SMITH

CLENIA  sulfacetamide sodium and sulfur  cream

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0245-0169 Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength sulfacetamide sodium (sulfacetamide) sulfacetamide 100 mg  in 1 g sulfur (sulfur) sulfur 50 mg  in 1 g

Inactive Ingredients Ingredient Name Strength allantoin   edetate disodium   Glyceryl Monostearate   isopropyl myristate   methylparaben   polyoxyl 8 stearate   propylene glycol   propylparaben   water   sodium thiosulfate   stearic acid   xanthan gum

Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 0245-0169-01 1 TUBE In 1 CARTON contains a TUBE 1 28 g In 1 TUBE This package is contained within the CARTON (0245-0169-01) 2 0245-0169-20 1 TUBE In 1 CARTON contains a TUBE 2 3 g In 1 TUBE This package is contained within the CARTON (0245-0169-20)

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Unapproved drug other		09/01/2009

CLENIA  sulfacetamide sodium and sulfur  cream

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0245-0168 Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength sulfacetamide sodium (sulfacetamide) sulfacetamide 100 mg  in 1 g sulfur (sulfur) sulfur 50 mg  in 1 g

Inactive Ingredients Ingredient Name Strength butylated hydroxytoluene   edetate disodium   Glyceryl Monostearate   polyoxyl 100 stearate   magnesium aluminum silicate   methylparaben   propylene glycol   propylparaben   water   silicon dioxide   sodium thiosulfate   stearic acid   titanium dioxide   xanthan gum

Product Characteristics Color WHITE Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 0245-0168-06 1 BOTTLE In 1 CARTON contains a BOTTLE 1 170 g In 1 BOTTLE This package is contained within the CARTON (0245-0168-06) 2 0245-0168-12 1 BOTTLE In 1 CARTON contains a BOTTLE 2 340 g In 1 BOTTLE This package is contained within the CARTON (0245-0168-12) 3 0245-0168-20 20 PACKET In 1 CARTON contains a PACKET 3 5 g In 1 PACKET This package is contained within the CARTON (0245-0168-20)

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Unapproved drug other		09/01/2009

Labeler - Upsher-Smith Laboratories, Inc (047251004)

Establishment
Name	Address	ID/FEI	Operations
Upsher-Smith Laboratories, Inc		047251004	ANALYSIS

Establishment
Name	Address	ID/FEI	Operations
Contract Pharmaceuticals Limited Canada		208761249	ANALYSIS, MANUFACTURE

Establishment
Name	Address	ID/FEI	Operations
Innopharm		201939910	ANALYSIS

Revised: 09/2009Upsher-Smith Laboratories, Inc

More Clenia Cream resources

• Clenia Cream Side Effects (in more detail)
• Clenia Cream Use in Pregnancy & Breastfeeding
• Clenia Cream Drug Interactions
• Clenia Cream Support Group
• 0 Reviews for Clenia - Add your own review/rating

Compare Clenia Cream with other medications

• Acne
• Rosacea
• Seborrheic Dermatitis